Physician profile
Keith D Pitzer
NPI 1497919740
$445.71
in general payments reported to CMS, 2019-2025
9 companies · $52.75 in 2025
The $52.75 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $18.63 · 2021: $126 · 2022: $39.73 · 2023: $66.56 · 2024: $25.63 · 2025: $52.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $190.10 | 2019-2025 | |
| Mentor Worldwide LLC | $71.49 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $43.08 | 2023-2024 | |
| Sientra, INC. | $33.55 | 2022 | |
| Ethicon US, LLC | $27.90 | 2021 | |
| Integra Lifesciences Corporation | $26.50 | 2023 | Durasorb Monofilament Mesh |
| Kerecis Limited | $22.61 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $18.63 | 2020 | |
| Allergan, INC. | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Pitzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.